Frederick Freeman, MD
Otolaryngology · Hardeeville, SCNPI 1720054646
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,925 of the $3,900 with a category attached, or 75.0%. Microline Surgical Inc accounts for 75.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $3,005 and has fallen 78.0% since, to $661 in 2024.
Across 27 payments — averaging $144.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microline Surgical Inc$3K
- Stryker$626
- GSK$51
- AstraZeneca$49
- Amgen$39
- Novo Nordisk$30
- plus $181 from 10 others
What the payments were for
- Consulting fees$2,92575%
- Travel & lodging$46312%
- Food & beverage$51213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microline Surgical Inc | 1 | $2,925 |
| Stryker | 4 | $626 |
| GSK | 3 | $51 |
| AstraZeneca | 3 | $49 |
| Amgen | 3 | $39 |
| Novo Nordisk | 2 | $30 |
| AbbVie | 1 | $25 |
| Abbott | 1 | $24 |
| Merck | 2 | $23 |
| Lundbeck LLC | 1 | $18 |
| Optinose US, Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$463
- XPRESS LOPROFILE$128
How this compares
$3,900 in reported general payments places this provider in the 80th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 75 | $828 |
| Ipratropium Bromide | 21 | $536 |
| Cephalexin | 19 | $193 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $132 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Hardeeville
- Shaun NguyenCharleston$973K
- Rodney SchlosserCharleston$382K
- Zachary SolerCharleston$67K
- Peter HorwichNorth Charleston$33K
- Eugene BrownCharleston$28K
- Jason NewmanCharleston$26K
- Joshua HornigCharleston$25K
- Ashli OrourkeCharleston$21K
- Alexandra KejnerCharleston$19K
- Evan GraboyesCharleston$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.